Cargando…

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare

The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilic Curcic, Ines, Cigrovski Berkovic, Maja, Kizivat, Tomislav, Canecki Varzic, Silvija, Smolic, Robert, Smolic, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192260/ https://www.ncbi.nlm.nih.gov/pubmed/34168727 http://dx.doi.org/10.4239/wjd.v12.i6.780

Ejemplares similares

Prehabilitation of overweight and obese patients with dysglycemia awaiting bariatric surgery: Predicting the success of obesity treatment
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2022)

Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing?
por: Curcic, Ines Bilic, et al.
Publicado: (2019)

Management of Glycemia during Acute Aerobic and Resistance Training in Patients with Diabetes Type 1: A Croatian Pilot Study
por: Ivandic, Marul, et al.
Publicado: (2023)

Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes
por: Canecki-Varzic, Silvija, et al.
Publicado: (2023)

Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Canecki-Varžić, Silvija, et al.
Publicado: (2016)

Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes
por: Ninčević, Vjera, et al.
Publicado: (2019)

Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update
por: Ćurčić, Ines Bilić, et al.
Publicado: (2022)

IMPACT OF GRAVES’ DISEASE AND ANTITHYROID DRUG THERAPY ON BONE MINERAL DENSITY – PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL RELEVANCE
por: Mudri, Dunja, et al.
Publicado: (2022)

Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome
por: Polic, Melita Vuksic, et al.
Publicado: (2018)

Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study
por: Canecki Varzic, Silvija, et al.
Publicado: (2021)

Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications
por: Kizivat, Tomislav, et al.
Publicado: (2020)

Antioxidant Pre-Treatment Reduces the Toxic Effects of Oxalate on Renal Epithelial Cells in a Cell Culture Model of Urolithiasis
por: Kizivat, Tomislav, et al.
Publicado: (2017)

Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy
por: Mihaljević, Vjera, et al.
Publicado: (2022)

Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
por: Omanovic Kolaric, Tea, et al.
Publicado: (2022)

Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy
por: Ninčević, Vjera, et al.
Publicado: (2022)

Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients’ Population
por: Bojanic, Kristina, et al.
Publicado: (2020)

The Association of Personality Traits and Parameters of Glycemic Regulation in Type 1 Diabetes Mellitus Patients Using isCGM
por: Sladić Rimac, Daria, et al.
Publicado: (2022)

Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
por: Schönberger, Ema, et al.
Publicado: (2023)

What is the gut feeling telling us about physical activity in colorectal carcinogenesis?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2020)

NAFLD and Physical Exercise: Ready, Steady, Go!
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
por: Bojanić, Kristina, et al.
Publicado: (2018)

The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study
por: Gradiser, Marina, et al.
Publicado: (2015)

Association between Interleukin-10 Gene (-1082g/A) Polymorphism and Type 2 Diabetes, Diabetes-Related Traits, and Microvascular Complications in the Croatian Population
por: Canecki-Varžić, Silvija, et al.
Publicado: (2018)

Are We Compensating for the Lack of Physical Activity in Our Diabetic Patients with Treatment Intensification?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2017)

Semaglutide-eye-catching results
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

How far along are we in revealing the connection between metformin and colorectal cancer?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2021)

Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2022)

Long-Term Effectiveness of Liraglutide in Association with Patients’ Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2017)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018)

Anabolic androgenic steroid-induced liver injury: An update
por: Petrovic, Ana, et al.
Publicado: (2022)

Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor
por: Marinkovic-Radosevic, Jelena, et al.
Publicado: (2021)

Molecular Mechanisms of Resistance to Immune Checkpoint Inhibitors in Melanoma Treatment: An Update
por: Vukadin, Sonja, et al.
Publicado: (2021)

Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy
por: Khaznadar, Farah, et al.
Publicado: (2023)

Wnt Inhibitors and Bone Mineral Density in Patients with Graves’ Disease Treated with Antithyroid Drugs: A Preliminary Prospective Study
por: Mudri, Dunja, et al.
Publicado: (2022)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4aknde1phribth47fopnk8gt0k